TO: Board of Supervisors
FROM: County Counsel
MEETING DATE: March 14, 2023
DEPARTMENT CONTACT:
Christian Curtis
PHONE:
707-234-6885
ITEM TYPE: Consent Agenda
TIME ALLOCATED FOR ITEM: N/A
AGENDA TITLE:
title
Approval of Backstop Agreements with the Barron & Budd, P.C., and the California Attorney General in Relation to the Settlement Agreements with Johnson & Johnson, Janssen Pharmaceuticals, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc., and Janssen Pharmaceutica, Inc. (collectively "Janssen") Settlement and McKesson Corporation, Cardinal Health, Inc., and AmerisourceBergen Corporation (collectively "Distributors") Settlement
End
RECOMMENDED ACTION/MOTION:
recommendation
Approve backstop agreements with the Barron & Budd, P.C., and the California Attorney General in relation to the settlement agreements with Johnson & Johnson, Janssen Pharmaceuticals, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc., and Janssen Pharmaceutica, Inc. (collectively "Janssen") Settlement and McKesson Corporation, Cardinal Health, Inc., and AmerisourceBergen Corporation (collectively "Distributors") Settlement; and authorize Chair to sign same.
End
PREVIOUS BOARD/BOARD COMMITTEE ACTIONS:
This Board previously approved an agreement with Barron & Budd, P.C., Agreement No. 18-045, effective date April 22, 2018, under which Barron & Budd would provide legal services for the County to litigate, pursue and resolve claims and remedies against certain opioid manufactures and distributors.
SUMMARY OF REQUEST:
On August 6, 2021, Judge Polster of the US District Court for the Northern District of Ohio issued an Order in In Re National Prescription Opiate Litigation, addressing contingent attorney fee contracts between political subdivisions eligible to participate in the McKesson Corporation, Cardinal Health, Inc., and AmerisourceBergen Corporation (collectively "Distributors") Settlement and the Johnson & Johnson, Janssen Pharmaceuticals, Inc., Ortho-McNeil-...
Click here for full text